Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. 1992

T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
Department of Pharmacology, University of Texas Health Science Center, San Antonio.

This study prospectively evaluated the potential interaction between the oral anticoagulant warfarin and the quinolone antimicrobial agent ciprofloxacin. After a 10-day placebo lead-in phase, 16 patients stabilized with long-term warfarin therapy were randomized to receive ciprofloxacin 500 mg or a matching placebo twice/day for 10 days. International normalized ratios (INRs) measured by both standard laboratory analysis and by Coumatrak (finger-stick) methods were evaluated at 3- to 5-day intervals. No patient experienced a significant increase in INR. No patient experienced a bleeding event. These data support the fact that a warfarin-ciprofloxacin interaction does not routinely occur at this dosage and duration of ciprofloxacin therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
November 1998, British journal of haematology,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
July 1995, Archives of internal medicine,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
October 2018, Circulation,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
February 2014, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
July 2016, Journal of the American Heart Association,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
December 1991, DICP : the annals of pharmacotherapy,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
October 2022, Thrombosis journal,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
August 1989, American journal of ophthalmology,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
March 1989, Clinical pharmacy,
T M Bianco, and H I Bussey, and L E Farnett, and W D Linn, and M K Roush, and Y W Wong
June 1991, The American journal of medicine,
Copied contents to your clipboard!